OncoBreak: Suboptimal Ovarian Care; Moles and Melanoma; Virtual Colonoscopy
News, features, and commentary about cancer-related issues
Diagnosis and treatment of ovarian cancer remain suboptimal despite advances that have lead to an improvement in overall survival, according to a new report commissioned by the Institute of Medicine.
Borrowing from colleagues north of the border, the American Society of Clinical Oncology has endorsed Cancer Care Ontario's clinical guideline recommending active surveillance "for most patients with low-risk (Gleason score ≤ 6) localized prostate cancer."
A new study debunks the perception that melanoma disproportionately affects people who have a lot of moles. (Time)
The FDA has expanded its approval of the breast cancer hormonal agent fulvestrant (Faslodex) to include use in combination with palbociclib (Ibrance) in women whose cancer progressed during or after standard endocrine therapy. (Business Wire)
Researchers at MD Anderson Cancer Center in Houston have identified what could be the hypothesized prostate stem cells that provide the genesis for aggressive forms of prostate cancer, reported in Nature Communications.
Treating liver metastases with radiofrequency ablation may sensitize colorectal cancer cells to treatment with PD-1 immunotherapy, U.S. and Chinese investigators reported in Clinical Cancer Research.
During National Colon Cancer Awareness Month, the American Cancer Society and multiple other organizations are promoting and providing information about the disease and how to prevent it ...
... And numerous groups showed up in Washington to urge Congress to pass pending legislation to authorize Medicare coverage of CT colonography, also known as virtual colonoscopy. (Health Care Business Daily News)
As of June 1, San Francisco will join about 100 other cities nationwide -- and one state, Hawaii -- in raising the legal smoking age to 21. (CNN)
Borrowing from colleagues north of the border, the American Society of Clinical Oncology has endorsed Cancer Care Ontario's clinical guideline recommending active surveillance "for most patients with low-risk (Gleason score ≤ 6) localized prostate cancer."
The FDA has expanded its approval of the breast cancer hormonal agent fulvestrant (Faslodex) to include use in combination with palbociclib (Ibrance) in women whose cancer progressed during or after standard endocrine therapy. (Business Wire)
Researchers at MD Anderson Cancer Center in Houston have identified what could be the hypothesized prostate stem cells that provide the genesis for aggressive forms of prostate cancer, reported in Nature Communications.
Treating liver metastases with radiofrequency ablation may sensitize colorectal cancer cells to treatment with PD-1 immunotherapy, U.S. and Chinese investigators reported in Clinical Cancer Research.
During National Colon Cancer Awareness Month, the American Cancer Society and multiple other organizations are promoting and providing information about the disease and how to prevent it ...
As of June 1, San Francisco will join about 100 other cities nationwide -- and one state, Hawaii -- in raising the legal smoking age to 21. (CNN)
Không có nhận xét nào:
Đăng nhận xét